12th Edition, By Mottram
Chapter 1 - 13 Updated
,ChapterN1:NIndicationsNforNPulmonaryNFunctionNTestingNTestNBank
MULTIPLENCHOICE
1. WhoNfirstNpopularizedNspirometryNforNtheNevaluationNofNpulmonaryNfunction?
a. AugustNandNMarieNKrogh
b. AlvanNBarach
c. JohnNSeveringhaus
d. JohnNHutchinson
ANS:ND
HutchinsonNpopularizedNtheNconceptNofNusingNVCNtoNassessNlungNfunction,NandNtheNnamesNh
eNgaveNtoNseveralNotherNlungNcompartmentsNareNstillNusedNtoday.
DIF: 1 REF: p.N2 OBJ: NoneN MSC:NNBRC:NNone
2. WhichNofNtheNfollowingNareNindicationsNforNperformingNspirometry?
1. AssessNtheNriskNofNlungNresection.
2. DetermineNtheNresponseNtoNbronchodilatorNtherapy.
3. AssessNtheNseverityNofNrestrictiveNlungNdisease.
4. QuantifyNtheNextentNofNCOPD.
a. 1N andN 4
b. 2N andN 3
c. 1N,N2,NandN 4
d. 2N,N3,NandN 4
ANS:NC
SpirometryNcannotNassessNseverityNofNrestriction;NforNthatNyouNneedNtoNmeasureNlungNvolum
esN(NseeNBoxN1-2,NChapterN 1).
DIF: 1 REF: p.N7 OBJ: EL-2 MSC:NNBRC:NNone
,3. TheNmainNindicationNforNtheNmeasurementNofNlungNvolumesNisNtoNdoNwhichNofNtheNfollowing
?
a. DiagnoseNorNassessNtheNseverityNofNrestriction.
b. EvaluateNtheNseverityNofNpulmonaryNhypertension.
c. DetermineNtheNlevelNofNcardiopulmonaryNfitness.
d. AssessNtheNriskNofNabdominalNsurgicalNprocedures.
ANS:NA
TheNmostNcommonNreasonNforNmeasuringNlungNvolumesNisNtoNidentifyNrestrictiveNlungNdise
ase.NDIF: 1 REF: p.N35 OBJ: EL-2 MSC:NNBRC:NNone
4. DLCONmeasurementsNmayNbeNindicatedNtoNevaluateNpulmonaryNinvolvementNinNwhichNofN
theNfollowingNsystemicNdiseases?
a. Asthma
b. Sarcoidosis
c. ExertionalNhypoxemia
, Stuvia.comN-
NTheNMarketplaceNtoNBuyNandNSellNyourNStudyNMaterial
d. Guillain-BarréNsyndrome
ANS:NB
SarcoidosisNisNtheNonlyNsystemicNdiseaseNlistedNthatNaffectsNgasNexchang
e.NDIF:N1NREF:Np.N9N|Np.N19N|Np.N21N|Np.N35NOBJ:NEL-2NMSC:NNBRC:NNone
5. BloodNgasNanalysisNisNusedNwithNpatientsNwithNCOPDNtoNdoNwhichNofNt
heNfollowing?
a. MonitorNairwayNresponsiveness.
b. DetermineNlevelNofNcardiopulmonaryNfitness.
c. DetectNpulmonaryNhypertension.
d. AssessNneedNforNsupplementaryNO2.
ANS:ND
BloodNgasNanalysisNisNmostNcommonlyNusedNtoNdetermineNtheNneedNforNsupplementalNoxy
genNandNtoNmanageNpatientsNwhoNrequireNventilatoryNsupport.
DIF: 2 REF: p.N15 OBJ: EL-
1NMSC:NNBRC:NCPFTN2A-2
6. WhichNofNtheNfollowingNcauseNemphysema?
1. 1-NAntitrypsinNdeficiency
2. ExposureNtoNenvironmentalNpollutants
3. RadiationNtherapy
4. CigaretteNsmoking
a. 1N andN 2
b. 3N andN 4
c. 1N,N2,NandN 4
d. 2N,N3,NandN 4
ANS:NC
EmphysemaNisNcausedNprimarilyNbyNcigaretteNsmoking.NSomeNemphysemaNisNcausedNbyNtheN
absenceNofNaNprotectiveNenzyme.NChronicNexposureNtoNenvironmentalNpollutantsNcanNalsoNc
ontributeNtoNtheNdevelopmentNofNemphysema.
DIF: 1 REF: p.N11 OBJ: EL-3N|NAL-2 MSC:NNBRC:NNone
7. AnNadultNpatientNcomplainsNofNchestNtightnessNandNcoughNwheneverNheNjogsNinNcoldNwea
ther.NTheseNsymptomsNareNconsistentNwithNwhichNofNtheNfollowing?
a. CysticNfibrosis
b. Asthma
c. PulmonaryNhypertension
d. IdiopathicNpulmonaryNfibrosis
|